Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets
Open Access
- 28 June 2021
- journal article
- review article
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 2 (3) , 266-291
Abstract
Metastasis is still the primary cause of cancer-related mortality. However, the underlying mechanisms of cancer metastasis are not yet fully understood. Currently, the epithelial-mesenchymal transition, metabolic remodeling, cancer cell intercommunication and the tumor microenvironment including diverse stromal cells, are reported to affect the metastatic process of cancer cells. Calcium ions (Ca2+) are ubiquitous second messengers that manipulate cancer metastasis by affecting signaling pathways. Diverse transporter/pump/channel-mediated Ca2+ currents form Ca2+ oscillations that can be decoded by Ca2+-binding proteins, which are promising prognostic biomarkers and therapeutic targets of cancer metastasis. This paper presents a review of the advances in research on the mechanisms underlying cancer metastasis and the roles of Ca2+-related signals in these events.Keywords
This publication has 144 references indexed in Scilit:
- Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vesselsNature Communications, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinomaCell Calcium, 2010
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growthEuropean Journal of Cancer, 2010
- Regulation of Adhesion Dynamics by Calpain-mediated Proteolysis of Focal Adhesion Kinase (FAK)Journal of Biological Chemistry, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Models, mechanisms and clinical evidence for cancer dormancyNature Reviews Cancer, 2007
- A mutation in Orai1 causes immune deficiency by abrogating CRAC channel functionNature, 2006